The cybersecurity in healthcare market map
From data loss prevention to IoT security, we map 135+ companies helping healthcare organizations combat cyber threats.
From data loss prevention to IoT security, we map 135+ companies helping healthcare organizations combat cyber threats.
Our expert is diving into the biggest trends shaping the dealmaking landscape in 2025.
From the drought in dealmaking to a new record for early-stage companies, we break down the trends reshaping insurtech using CB Insights data.
2024 broke records for AI, with funding surpassing $100B. As the AI arms race intensifies, staying ahead of the trends and opportunities has never been more critical.
CVCs plunge headfirst into AI, prioritize early-stage deals, and downshift on Asia. We break down the trends reshaping corporate venture capital using CB Insights data.
From a new breed of AI unicorns to the M&A wave, we look at key changes in the AI landscape using CB Insights data.
We surveyed 50 senior strategy leaders to understand their genAI implementation tactics — and why some teams are seeing better results than others.
From AI’s ascendance to cautious dealmaking, we break down the trends reshaping digital health in 2024 using CB Insights data.
In this webinar, our expert explores how leading enterprises are integrating genAI into their strategies to drive results and stay ahead of the competition.
From AI’s banner year to an 8-year low in global dealmaking, we break down key changes in the venture landscape using CB Insights data.
AI promises to accelerate the path from bench to bedside. Using CB Insights data, we highlight emerging markets in the preclinical phase that are ripe for pharma investments and partnerships.
How did venture fare in 2024, and what’s ahead for 2025? In this webinar, our expert breaks down the year’s funding landscape, why it matters, and the trends set to shape the future.
We analyze funding and acquisitions data, clinical progress, and partnership strategies to help pharma companies and investors navigate the maturing AI landscape in drug discovery.
Pharma giants and diagnostic testing leaders looking to expand in cancer detection should watch high-momentum liquid biopsy startups like Harbinger Health and Delfi Diagnostics.
Nearly 1 in 2 new unicorns is an AI company. We visualize every billion-dollar startup around the globe and break down emerging areas of opportunity.
The Digital Health 50 is CB Insights’ annual list of the most promising digital health startups in the world.
We mined Roche’s acquisitions, investments, and partnerships to discern the company's strategic priorities. Here’s what pharma and diagnostics companies need to pay attention to.
Discover the key trends our experts anticipate will shape the tech landscape in 2025.
The future of LLMs. Caregiving humanoid robots. Crypto’s baby steps. We use CB Insights data to uncover 15 emerging trends that will shape the tech landscape for years to come.
From in-home humanoids to autonomous labs, we highlight the growing opportunities in robotics markets for providers and other healthcare stakeholders.
We use CB Insights data to break down the AI trends highlighted at the conference that insurers should watch to stay ahead of competitors.
Insurtech funding holds steady, buoyed by multiple $100M+ mega-rounds. We break down the global insurtech landscape to help leading insurers and investors understand emerging players and areas of activity.
Dive into the latest AI activity, and discover the emerging trends our data is signaling.
Discover the 50 private digital health companies set to transform healthcare.
We explore emerging technologies in energy production, AI computing hardware, support infrastructure, and AI cloud services that data center stakeholders should invest in for growth.
CVCs show heightened interest in early-stage rounds, even as CVC dealmaking falls to its lowest level since 2018.